Concepedia

Author

Masao Nawata

University of Occupational and Environmental Health JapanORCID

Also Known As

M Nawata, M. Nawata, MASAO NAWATA, Masao NAWATA, Masao Nawata

66

Publications

2.5K

Citations

27

H-Index

50

Concepts

All Affiliations

University of Occupational and Environmental Health JapanSaitama Medical UniversitySocial Insurance Saitama Chuo HospitalTokyo Women's Medical UniversityJuntendo University Shizuoka Hospital
MN

About

Masao Nawata is an author at University of Occupational and Environmental Health Japan specializing in medicine, autoimmune disease, and rheumatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

12

537

2

Immunology

10

11

483

3

Allergy

4

4

193

4

Diabetes

1

1

17

5

Gastroenterology

1

1

72

Masao Nawata

×

33

Publications

2.2K

Citations

25

H-Index

YearCitations

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

Kazuyoshi Saito, Daisuke Kawabata, Y. Imura,

Annals of the Rheumatic Diseases

2006

336

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

Yoshiya Tanaka, Tsutomu Takeuchi, Tsuneyo Mimori,

Annals of the Rheumatic Diseases

2010

278

Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab

Masaki Tokunaga, Koichi Fujii, Kazuyoshi Saito,

Lara D. Veeken

2004

176

Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis

Shizuyo Tsujimura, Kazuyuki Saito, Masao Nawata,

Annals of the Rheumatic Diseases

2007

107

Cytomegalovirus infection in patients with systemic lupus erythematosus.

Iwao Sekigawa, Masao Nawata, Nathalie Séta,

PubMed

2003

98

Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study

Tsutomu Takeuchi, Yoshiya Tanaka, Koichi Amano,

Lara D. Veeken

2011

89

Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus

Jun Ishizaki, Kuniaki Saito, Masao Nawata,

Lara D. Veeken

2014

78

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease

S. Iwata, Kazuyoshi Saito, Kunihiro Yamaoka,

Modern Rheumatology

2010

72

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2)

Yoshiya Tanaka, Tsutomu Takeuchi, Eisuke Inoue,

Modern Rheumatology

2008

69

Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody

Keiko Nishida, Yosuke Okada, Masao Nawata,

Endocrine Journal

2008

68

Page 1